Results 131 to 140 of about 38,106 (211)

A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer. [PDF]

open access: yesFront Oncol
Di Maio M   +8 more
europepmc   +1 more source

Correction: Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus. [PDF]

open access: yesActa Diabetol
Gallen G   +12 more
europepmc   +1 more source

The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast. [PDF]

open access: yesOncol Ther
Halmos B   +17 more
europepmc   +1 more source

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer. [PDF]

open access: yesBMC Cancer
Boegemann M   +15 more
europepmc   +1 more source

Expanding the scope of human immunology in the <i>Journal of Human Immunity</i>. [PDF]

open access: yesJ Hum Immun
Brodin P   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy